These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
60 related items for PubMed ID: 2152369
21. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors. Boteju LW, Nikiforovich GV, Haskell-Luevano C, Fang SN, Zalewska T, Stropova D, Yamamura HI, Hruby VJ. J Med Chem; 1996 Sep 27; 39(20):4120-4. PubMed ID: 8831778 [Abstract] [Full Text] [Related]
22. Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor. Pearson RK, Miller LJ, Hadac EM, Powers SP. J Biol Chem; 1987 Oct 05; 262(28):13850-6. PubMed ID: 3654639 [Abstract] [Full Text] [Related]
23. A new probe for affinity labelling pancreatic cholecystokinin receptor with minor modification of its structure. Fourmy D, Lopez P, Poirot S, Jimenez J, Dufresne M, Moroder L, Powers SP, Vaysse N. Eur J Biochem; 1989 Nov 06; 185(2):397-403. PubMed ID: 2583188 [Abstract] [Full Text] [Related]
24. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential. Behr TM, Béhé M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W. Clin Cancer Res; 1999 Oct 06; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353 [Abstract] [Full Text] [Related]
25. Photoaffinity labeling of central cholecystokinin receptors with high efficiency. Thiele C, Fahrenholz F. Biochemistry; 1993 Mar 23; 32(11):2741-6. PubMed ID: 8457542 [Abstract] [Full Text] [Related]
26. Preparation of radiolabeled photolabile probes of high specific radioactivity for affinity labeling. Miller LJ, Hadac EM, Powers SP. Anal Biochem; 1994 Aug 01; 220(2):434-5. PubMed ID: 7978292 [No Abstract] [Full Text] [Related]
27. Establishment of a new short, protease-resistant, affinity labeling reagent for the cholecystokinin receptor. Pearson RK, Powers SP, Hadac EM, Gaisano H, Miller LJ. Biochem Biophys Res Commun; 1987 Aug 31; 147(1):346-53. PubMed ID: 2443134 [Abstract] [Full Text] [Related]
28. Molecular approximations between residues 21 and 23 of secretin and its receptor: development of a model for peptide docking with the amino terminus of the secretin receptor. Dong M, Lam PC, Gao F, Hosohata K, Pinon DI, Sexton PM, Abagyan R, Miller LJ. Mol Pharmacol; 2007 Aug 31; 72(2):280-90. PubMed ID: 17475809 [Abstract] [Full Text] [Related]
29. Effect of food restriction on plasma cholecystokinin levels and exocrine pancreatic function in rats. Chowdhury P, Rayford PL. Ann Clin Lab Sci; 2001 Oct 31; 31(4):376-82. PubMed ID: 11688849 [Abstract] [Full Text] [Related]
30. Photoaffinity cross-linking of a radioiodinated probe, 125I-A55453, into alpha 1-adrenergic receptors. Dickinson KE, Leeb-Lundberg LM, Heald SL, Wikberg JE, DeBernardis JF, Caron MG, Lefkowitz RJ. Mol Pharmacol; 1984 Sep 31; 26(2):187-95. PubMed ID: 6090880 [Abstract] [Full Text] [Related]
31. Direct identification of the agonist binding site in the human brain cholecystokininB receptor. Anders J, Blüggel M, Meyer HE, Kühne R, ter Laak AM, Kojro E, Fahrenholz F. Biochemistry; 1999 May 11; 38(19):6043-55. PubMed ID: 10320330 [Abstract] [Full Text] [Related]
32. Biochemical characterization of the pancreatic cholecystokinin receptor: a possible marker of cell differentiation and development. Miller LJ, Powers SP. Scand J Gastroenterol Suppl; 1988 May 11; 151():104-7. PubMed ID: 3227313 [Abstract] [Full Text] [Related]
33. The CCK receptor on pancreatic plasma membranes: binding characteristics and covalent cross-linking. Sakamoto C, Williams JA, Wong KY, Goldfine ID. FEBS Lett; 1983 Jan 10; 151(1):63-6. PubMed ID: 6297990 [Abstract] [Full Text] [Related]
34. Differential spatial approximation between secretin and its receptor residues in active and inactive conformations demonstrated by photoaffinity labeling. Dong M, Hosohata K, Pinon DI, Muthukumaraswamy N, Miller LJ. Mol Endocrinol; 2006 Jul 10; 20(7):1688-98. PubMed ID: 16513792 [Abstract] [Full Text] [Related]
35. Identification and localization of cholecystokinin-binding sites on rat pancreatic plasma membranes and acinar cells: a biochemical and autoradiographic study. Rosenzweig SA, Miller LJ, Jamieson JD. J Cell Biol; 1983 May 10; 96(5):1288-97. PubMed ID: 6841449 [Abstract] [Full Text] [Related]
36. Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe. Ding XQ, Dolu V, Hadac EM, Holicky EL, Pinon DI, Lybrand TP, Miller LJ. J Biol Chem; 2001 Feb 09; 276(6):4236-44. PubMed ID: 11050076 [Abstract] [Full Text] [Related]
37. Heterogeneity of cholecystokinin receptors in pancreas. Madison LD, Jamieson JD, Rosenzweig SA. Biochem Biophys Res Commun; 1987 Mar 13; 143(2):761-7. PubMed ID: 3105532 [Abstract] [Full Text] [Related]
38. Structural analysis of a distinct subtype of CCK receptor on human gastric smooth muscle tumors. Pearson RK, Hadac EM, Miller LJ. Am J Physiol; 1989 Jun 13; 256(6 Pt 1):G1005-10. PubMed ID: 2735406 [Abstract] [Full Text] [Related]
39. Gallbladder CCK receptors: species differences in glycosylation of similar protein cores. Schjoldager B, Molero X, Miller LJ. Regul Pept; 1990 May 21; 28(3):265-72. PubMed ID: 2377742 [Abstract] [Full Text] [Related]
40. Biochemical characterization of a subtype pancreatic cholecystokinin receptor and of its agonist binding domain. Poirot SS, Dufresne M, Jiménez J, Vaysse N, Fourmy D. J Recept Res; 1992 May 21; 12(2):233-53. PubMed ID: 1583623 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]